Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-107983
Filing Date
2025-08-13
Accepted
2025-08-13 16:00:58
Documents
69
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgvn-20250630.htm   iXBRL 10-Q 2450819
2 EX-31.1 lgvn-ex31_1.htm EX-31.1 14829
3 EX-31.2 lgvn-ex31_2.htm EX-31.2 14876
4 EX-32.1 lgvn-ex32_1.htm EX-32.1 13532
5 GRAPHIC img238713470_0.jpg GRAPHIC 21270
  Complete submission text file 0000950170-25-107983.txt   9634936

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lgvn-20250630.xsd EX-101.SCH 1279648
72 EXTRACTED XBRL INSTANCE DOCUMENT lgvn-20250630_htm.xml XML 1553628
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 251211281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)